CU Anschutz Wins FDA Clearance for CAR T Cancer Trial
Aurora, Colorado, U.S., September 10, 2026 University of Colorado Anschutz Medical Campus (CU Anschutz) has received U.S. Food and...
Pediatric Cancer
Advertisement
BrainChild Bio Initiates Pivotal Phase 2 Trial of BCB-276 for DIPG
SEATTLE, Washington and CAMBRIDGE, Massachusetts — September 8, 2026 BrainChild Bio, Inc. announced the initiation of the pivotal Phase...
Dana-Farber Identifies CDK8 as Promising Target for Childhood Cancer
Boston, Massachusetts, USA | July 16, 2026 Dana-Farber Cancer Institute researchers have identified CDK8 as a promising therapeutic target...
RedHill’s Opaganib Gains FDA Rare Pediatric Disease Status
RALEIGH, North Carolina, USA & TEL AVIV, Israel – June 9, 2026 RedHill Biopharma has received a significant regulatory...
Advertisement
